Industry Updates
Current Issue:
- Expanding the Role of Myosin Inhibition in Hypertrophic Cardiomyopathy — A Tale of Two Conditions
- Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
- Hypertrophic Cardiomyopathy
- Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
- Multidomain Rehabilitation for Older Patients with Myocardial Infarction
Food and Drug Administration:
- Green Lumber Holding, LLC Issues Consumer Alert on Counterfeit Products Following FDA Findings
- Manual Resuscitator Recall: Ambu Inc. Removes SPUR II Resuscitators Due to Blocked Manometer Port
- Breathing Circuit Set Recall: Hamilton Medical, Inc. Removes Coaxial Breathing Circuit Set Due to Possible Inner Blue Tube Cracks That May Impact Ventilation
- Mobile Power Unit AC Power Cord Recall: Abbott Medical Removes AC Power Cord Associated with HeartMate Mobile Power Unit (MPU) Due to Potential Risk of the Cord Not Locking into Place
- DermaRite Industries Expands Voluntary Nationwide Recall Due to Potential Burkholderia cepacia Contamination